The primary role of the Thoracic/Head & Neck Oncology MEL is to engage in meaningful peer-to-peer scientific dialog with healthcare system National Thought Leaders (NTLs) within a defined geography. The MEL conducts critical activities that support advancing science, educating on evolving clinical practices, transforming science into patient care, and facilitating the development of new research collaborations (including Investigator Initiated Trials and Real-World Evidence). This role is field-based and regional in scope, with the employee expected to spend approximately 50 - 60% of their time in the field interacting with external stakeholders, including investigators and clinical thought leaders while supporting internal stakeholders and maintaining a high level of therapeutic expertise.